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Abstract
Background: Gelsolin, an actin capping protein of osteoclast podosomes, has a unique function
in regulating assembly and disassembly of the podosome actin filament. Previously, we have
reported that osteopontin (OPN) binding to integrin αvβ3  increased the levels of gelsolin-
associated polyphosphoinositides, podosome assembly/disassembly, and actin filament formation.
The present study was undertaken to identify the possible role of polyphosphoinositides and
phosphoinositides binding domains (PBDs) of gelsolin in the osteoclast cytoskeletal structural
organization and osteoclast function.
Results:  Transduction of TAT/full-length gelsolin and PBDs containing gelsolin peptides into
osteoclasts demonstrated: 1) F-actin enriched patches; 2) disruption of actin ring; 3) an increase in
the association polyphosphoinositides (PPIs) with the transduced peptides containing PBDs. The
above-mentioned effects were more pronounced with gelsolin peptide containing 2 tandem repeats
of PBDs (PBD (2)). Binding of PPIs to the transduced peptides has resulted in reduced levels of PPIs
association with the endogenous gelsolin, and thereby disrupted the actin remodeling processes in
terms of podosome organization in the clear zone area and actin ring formation. These peptides
also exhibited a dominant negative effect in the formation of WASP-Arp2/3 complex indicating the
role of phosphoinositides in WASP activation. The TAT-PBD gelsolin peptides transduced
osteoclasts are functionally defective in terms of motility and bone resorption.
Conclusions: Taken together, these data demonstrate that transduction of PBD gelsolin peptides
into osteoclasts produced a dominant negative effect on actin assembly, motility, and bone
resorption. These findings indicate that phosphoinositide-mediated signaling mechanisms regulate
osteoclast cytoskeleton, podosome assembly/disassembly, actin ring formation and bone
resorption activity of osteoclasts.
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Background
Phosphoinositides are involved in modulating a variety of
actin regulatory proteins [1] as well as promoting filament
cross-linking to form stable, bundled actin fibers [2].
Phosphoinositide kinases comprise a unique family of
enzymes that catalyze the phosphorylations of phosphati-
dylinositol and its phosphorylated metabolites to pro-
duce seven phosphoinositides [3] with PtdIns 4,5 P2
being the most active one [4]. PtdIns 4,5 P2 (PtdIns P2)
regulates several actin-binding proteins, including gelso-
lin, profilin, α-actinin, and vinculin to promote actin
polymerization [4-7]. A number of phosphoinositide
binding motifs have been identified in several cytoskeletal
as well as structural proteins. Phosphoinositides binding
with these domains are highly dynamic, and rapidly
reversible [8-10]. Interaction of phosphoinositides with
the specific binding domains helps to coordinate the
assembly of one to several signaling molecules. These
molecules regulate cellular signal transduction processes
involving stress fiber and focal adhesion formation
[11,12]. Our previous studies have provided insights into
the roles of phosphoinositides in gelsolin function, in the
regulation of actin reorganization, and podosome assem-
bly/disassembly in avian and mouse osteoclasts [13-16].
Cell shape changes and motility are directly related to
structural dynamics of actin cytoskeleton and function of
actin binding proteins. Actin binding proteins comprise a
large family of proteins with distinct properties such as
severing, capping, cross linking, and nucleation. Actin fil-
ament remodeling is a critical element of cell motility
[17]. Besides cell motility, actin binding proteins and
actin remodeling play crucial roles in several cellular
responses, including, cell differentiation, secretion, and
cell shape changes [18-21]. Gelsolin is one of the actin
binding proteins that regulates actin assembly and disas-
sembly. By a variety of mechanisms gelsolin controls the
length of actin filaments in vitro, as well as cell shape
changes and motility in vivo [22]. Gelsolin severs assem-
bled actin filaments, caps the fast growing plus ends, and
promotes growth of actin filament by creating nucleation
sites [23-25]. Binding of PtdIns P2 to gelsolin causes the
release of gelsolin from the actin filament end (uncap-
ping), providing a site for rapid monomer addition
[6,26,27]. We have demonstrated similar gelsolin uncap-
ping actions by PtdIns P2 in osteoclast podosome assem-
bly [13,15].
Osteoclasts are characterized by unique cell adhesion
structures found in highly motile cells called podosomes.
This type of cell adhesion structures is a property also
shared by several types of cancer cells and monocytes and/
or macrophages [28-31]. When the osteoclasts are cul-
tured on glass surfaces, multiple rows of podosomes are
localized in the area corresponding to the sealing zone of
osteoclasts [15,29,30,32]. A higher rate of osteoclast
motility is brought about by accelerated podosome
assembly and disassembly [33,34]. Podosomes consist of
an F-actin core surrounded by the actin-binding proteins
vinculin, talin, gelsolin, and α-actinin [16,32,35].
We have shown previously that osteopontin (OPN) bind-
ing to integrin αvβ3 stimulates the levels of gelsolin-asso-
ciated polyphosphoinositides such as PtdIns 3,4 P2,
PtdIns 4,5 P2 (PtdIns P2), and PtdIns 3,4,5 P3 (PtdIns P3)
in osteoclasts. The increase of PtdIns P2 levels associated
with gelsolin uncaps actin oligomers leading to an
increase in F-actin content and actin filament formation
[13-15]. Gelsolin deficiency blocks podosome assembly
and αvβ3-stimulated signaling related to motility in gelso-
lin null osteoclasts [15]. Gelsolin deficient osteoclasts,
macrophages, and fibroblasts are hypo motile and are par-
tially disabled [15,36].
A substantial body of studies on the structure-function
analysis in vitro has defined distinct domains of gelsolin
responsible for severing and capping of actin filaments as
well as phosphoinositides binding. Gelsolin contains 1–6
repeats of a 120–130 amino acid segment [20]. The 1–6
segments of gelsolin exist as two tandem homologous
halves, each of which contains a three fold segmental
repeat (segments S1-S3 and S4-S6, respectively
[27,37,38]. The amino- and carboxyl-halves are con-
nected by a linker, which is cleaved by caspase-3 in vivo
[39,40] and by many other proteases in vitro. The F-actin
binding domains reside within amino acid residues 161–
171 [27] and the two-phosphoinositide binding domains
(PBDs) have been identified in the S1 and S2 segments of
gelsolin. The amino acid sequences of PBDs (1 and 2) in
S1 and S2 segment of gelsolin are: YFKSGLKYKKG-
GVASGF (PBD1; 133 to 149 aa residues) and KHVVPNEV-
VVQRLFQVKGRR (PBD2; 150 to169 aa residues),
respectively [37]. In addition to these two PBDs, a third
site in the C-terminal part of gelsolin was identified
recently using fluorescent phosphoinositide derivatives
[41]. This site resides in amino acid residues 620–634
[42].
The sequence QRLFQVKGRR in PBD2 has been shown to
compete with intact gelsolin for binding polyphosphoi-
nositides when introduced into fibroblasts, platelets, and
neutrophils. It also blocked cell motility and actin assem-
bly in these cells [43-45]. Since gelsolin has a unique func-
tion in regulating assembly and disassembly of the
podosome actin filament [13,14], we addressed the ques-
tion whether phosphoinositides and actin binding pep-
tides of gelsolin would be able to block actin assembly
and bone resorption in osteoclasts. In this study, we char-
acterized the effects of gelsolin peptides containing PBDs
on cytoskeletal organization and osteoclast function.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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Transduction of gelsolin PBD peptides into osteoclasts
produced a dominant-negative effect on actin assembly,
actin ring formation, and bone resorption.
Results
Expression and purification of recombinant peptides
A schematic diagram of gelsolin constructs used in this
study is shown in Fig. 1 (Panel A). Cloning was performed
as described in the Methods section. Full-length gelsolin
and its fragments were purified as TAT-fusion peptides
using Ni-NTA column. Western analysis of the purified
peptides was performed with an antibody to HA (Panel
B). In an 8% SDS-PAGE (lanes 1–3), the purified 98.5 kDa
full-length gelsolin (FL-GSN; lane 1), 43 kDa carboxyl ter-
minal (COOH-GSN; lane 2) and 36 kDa middle gelsolin
peptides (Mid-GSN; lane 3) are shown. In a 15% SDS-
PAGE (lanes 4–7), the purified HIV-TAT fused 26 kDa
amino terminal (NH-GSN; lane 4), the 18.5 kDa two tan-
dem repeats of PBD (PBD (2); lane 5), the 13.5 kDa PBD
(lane 6) gelsolin peptides and the 6–8 kDa TAT-HA vector
peptide (lane 7) are shown. The NH-terminal fragment
(NH-GSN) contains the first PBD (133–149 amino acid
(aa) residues) and 2 aa residues (150KH151) of the sec-
ond PBD. Mid-GSN fragment (aa 256–491) does not con-
tain any PBDs but contains actin binding domain (ABD)
3 and part of ABD 4. The COOH-terminal fragment (aa
491-aa 755) contains the actin binding domains (ABDs)
5 and 6 in addition to the 17-aminoacid residue of ABD
4, which is missing in Mid-GSN fragment. The COOH-ter-
minal domain also contains the recently identified third
PBD, which resides within amino acid residues 620–634.
The amino terminal PBDs 1 and 2 reside in amino acid
residues 133–169. The PBD and the TAT sequence
together generate a polypeptide with MW 13.5 kDa con-
stituting PBD. The 2 tandem repeats of PBD (PBD (2))
and the TAT sequence together generate a polypeptide
with MW 18.5 kDa constituting PBD (2).
Phosphoinositides associate with the transduced gelsolin 
peptides containing PBD
To identify the association of phosphoinositides with
PBDs of gelsolin, TAT-HA fusion peptides of gelsolin, as
indicated in Fig. 2 (Panel A), were transduced into osteo-
clasts generated from mice for 45 min. at 37°C. Triton-
soluble lysates were prepared for immunoprecipitation
and Western analyses. Western analysis of HA immuno-
precipitates with an anti-PtdIns P2 antibody is shown in
Panel A. The anti-PtdIns P2 antibody recognized the fol-
lowing transduced peptides containing PBD: FL-GSN
(lane 2), NH-GSN (lane 5), COOH-GSN (lane 7), PBD
(lane 8) and PBD (2) (lane 9). Neither the Mid-GSN (lane
6) nor the control peptides (TAT-HA, lane 3; and HSV-TK,
lane 4) had any detectable association with PtdIns P2.
Immunoprecipitation with non-immune serum is shown
in lane 1. Immunoblots of SDS gels containing the various
gelsolin peptides prior to transduction were negative for
PtdIns P2 (data not shown).
To further analyze the phospholipids associated with the
transduced peptides, lipids associated with anti-HA
immunoprecipitates were extracted from osteoclasts
exposed to 32Pi and subjected to TLC analysis (Panel B).
Binding of PtdIns P2 and PtdIns P3 with FL-GSN (lane 1),
NH-GSN (lane 2), COOH-GSN (lane 3), PBD (2) (lane
4), and PBD (lane 5) were observed. Negligible amounts
of phosphoinositides were associated with either Mid-
GSN (lane 6) or TAT-HA (lane 7) peptides. A significant
increase in the binding of PtdIns P2 and PtdIns P3 was
observed with the PBD (2) (lane 4). The presence of an
additional PBD in the transduced protein enhances its
affinity to PtdIns P2 and PtdIns P3. Immunoprecipitation
with non-immune serum is shown in lane 8.
Osteopontin stimulates phosphoinositides association 
with the transduced peptides containing PBD
We next examined the effects of OPN on PtdIns P2 associ-
ation with the transduced peptides. Anti-HA immunopre-
cipitates made from lysates of osteoclasts treated as
indicated in Fig. 3 were immunoblotted with an anti-
PtdIns P2 antibody. OPN stimulated PtdIns P2 associa-
tion with the following transduced peptides: FL-GSN
(lane 2), COOH-GSN (lane 5), NH-GSN (lane 7) and the
gelsolin peptide containing 2 tandem repeats of PBD (2)
(lane 9). PBS-treated osteoclasts were used as control
(lanes 1, 4, 6, and 8). Neither PBS (lane 10) nor OPN
(lane 11) had any effect on the association PtdIns P2 with
the Mid-GSN fragment. Immunoprecipitation with non-
immune serum is shown in lanes 3 and 12. Western anal-
ysis with anti-HA (Fig. 3, panel B) demonstrates the levels
of transduced peptides immunoprecipitated in each lane
shown in Fig. 3 (Panel A). These experiments (Figs. 2 and
3) demonstrate that the transduced FL-Gsn and its frag-
ments containing PBD can associate with PtdIns P2 and
PtdIns P3.
Transduction of PBD containing gelsolin peptides 
decreases the association of polyphosphoinositides with 
endogenous gelsolin
We then addressed the question whether increasing the
intracellular levels of gelsolin peptides affected the func-
tion of endogenous gelsolin (Fig. 4). Osteoclast lysates,
which were immunodepleted for the transduced peptides
by immunoprecipitation with an anti-HA antibody, were
subjected to a second immunoprecipitation with an anti-
gelsolin antibody. One half of the gelsolin immunopre-
cipitates were used for Western analysis with anti-PtdIns
P2 antibody (Fig. 4, panel A) and the second half were
used for Western analysis with anti-gelsolin antibody to
detect the levels of gelsolin protein immunoprecipitated
(Fig. 4, panel B). Immunoprecipitations made with lysatesBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
Page 4 of 21
(page number not for citation purposes)
prepared from PBS- and OPN-treated osteoclasts were
used as positive control (Fig. 4; Panel A, lanes 1 and 2).
OPN stimulated PtdIns P2 association with gelsolin in
untransduced (lane 2), Hsv-TK (non-specific control, lane
4), and Mid-GSN fragment (lane 6) transduced osteo-
clasts as compared with the respective PBS-treated con-
trols (lanes 1, 3, and 5). A decrease in the basal level of
PtdIns P2 association with endogenous gelsolin was
observed in PBS-treated NH-GSN (lane 7), PBD- (lane
12), PBD (2) (lane 14), and FL-GSN (lane 16) peptides
transduced osteoclasts. OPN stimulation had minimal
effect on the increase in PtdIns P2 association with endog-
enous gelsolin in osteoclasts transduced with the above-
mentioned peptides (lanes 8, 13, 15, and 17) as compared
with the OPN-alone treated control osteoclasts (lane 2).
In osteoclasts transduced with TAT/FL-GSN protein, more
PtdIns P2 association was observed with the transduced
protein (Lane 17, indicated as TAT-gelsolin by an arrow)
than the endogenous gelsolin (indicated as gelsolin) in
osteoclasts treated with PBS (lane 16) and OPN (lane 17).
Panel A. Schematic diagram demonstrating various gelsolin constructs generated in HIV-TAT-expression vector Figure 1
Panel A. Schematic diagram demonstrating various gelsolin constructs generated in HIV-TAT-expression vec-
tor. Actin binding domain (S1-S6) and phosphoinositide binding domains (PBDs) are indicated in full-length gelsolin (FL-Gsn). 
Cloning was performed as described in the Methods Section. Phosphoinositides binding domains 1, 2, and 3 are shown in green 
color. Two-tandem repeats of first and second phosphoinositides binding domains (aa 133–169) were also cloned. This is rep-
resented as PBD (2) in the text. Panel B. Western analysis of the purified peptides using a HA antibody. Purified 
TAT-fused gelsolin peptides were subjected to 8% (lanes 1–3) and 15% SDS-PAGE (lanes 4–7). The blots were subjected to 
Western analysis with an antibody to HA. The results shown are representative of three independent experiments.
PBD1 &2 PBD3
aa22
160bp 2360bp
aa755
S1       S2         S3      S4       S5     S6
133-169aa 620-634aa
FL-Gsn; aa 160-2360
NH-Gsn (aa22-151)
PBD 1 & 2 (aa133-169)
Two tandem repeats of 
PBD 1 &2 (PBD(2); aa133-169)
Mid-Gsn (aa256-491)
COOH-Gsn (aa492-755)
PBD3
A
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Analysis of PtdIns P2 association with the transduced protein Figure 2
Analysis of PtdIns P2 association with the transduced protein. Panel A. Western analysis with an anti-PtdIns P2 anti-
body: Treatments are as indicated below the figure. Lysates were immunoprecipitated with an antibody to HA (lanes 2–9) or 
non-immune serum (NI; lane 1). The immunoprecipitates were subjected to 8% SDS-PAGE (lanes 1 to 3) or 15% SDS-PAGE 
(lanes 4 to 9) and Western analyzed with an antibody to PtdIns P2. PtdIns P2 binding to the transduced peptides is indicated 
with arrowheads. Arrows indicate IgG heavy chain (IgG HC). The results shown are representative of three independent 
experiments. Panel B. TLC analysis of the phospholipids associated with the anti-HA immunoprecipitates: 32P-labeled osteo-
clasts were subjected to various treatments as indicated in the figure. Osteoclast lysates made from these cells were subjected 
to immunoprecipitation with an antibody to HA. 32P-labeled phosphoinositides associated with anti-HA immunoprecipitates 
were analyzed by TLC. Arrows on the left side of the figure indicate the migration of PtdIns P2 and PtdIns P3. The results 
shown are representative of three independent osteoclast preparations and experiments.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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IgG heavy chain (IgG HC) is indicated by an arrow. The
levels of gelsolin protein immunoprecipitated are demon-
strated by Western analysis of the second half of the
immunoprecipitates with an anti-gelsolin antibody (Fig.
4, panel B). The transduced TAT/FL-GSN gelsolin was also
recognized by the gelsolin antibody in osteoclasts treated
with PBS and OPN (lanes 16 and 17). Although the trans-
duced level of PBD (2) is lower than FL-GSN, it exhibits
either equal or more blocking effects in the association of
PtdIns P2 with endogenous gelsolin (lanes 14 and 15).
Transduction of PBD containing gelsolin peptides 
decreases the interaction of PI3-Kinase with endogenous 
gelsolin
We have demonstrated that OPN stimulated tyrosine
phosphorylation of the p85 regulatory subunit of PI3-
kinase associated with gelsolin, and increased its activity
as measured by PtdIns P3 production in immune complex
phospholipid kinase assay in vitro [13,46]. Our recent
studies have defined unique biochemical properties of
gelsolin and have demonstrated strong phosphoi-
nositides-mediated interaction of PI 3-Kinase with gelso-
lin [16]. Hence, the possibility that the increased levels of
The effects of OPN or TAT-HA-protein transduction on PtdIns P2 association with the transduced peptides Figure 3
The effects of OPN or TAT-HA-protein transduction on PtdIns P2 association with the transduced peptides 
Osteoclasts were transduced with the indicated gelsolin peptides and treated with PBS (-) or OPN (+) as shown below the Fig-
ure. Lysates were immunoprecipitated with an antibody to HA (lanes 1, 2, 4–11) or non-immune serum (NI; lanes 3 & 12). The 
immunoprecipitates were subjected to 8% SDS-PAGE (lanes 1 and 2) or 15% SDS-PAGE (lanes 3–12). Panel A: Western analy-
sis with an antibody to PtdIns P2. Panel B: Western analysis with an antibody to HA. The immunoblot shown in panel A was 
stripped and blotted with a HA-antibody to detect the levels of transduced proteins immunoprecipitated in each lane. Arrow-
heads point to transduced proteins associated with PtdIns P2. Arrows indicate IgG heavy chain (IgG HC). The results repre-
sent one of three experiments performed from three separate osteoclast preparations.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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PtdIns P3 associated with the transduced PBD (2) could
be due to interaction of activated p85 regulatory subunit.
To investigate this possibility, osteoclast lysates were sub-
jected to immunoprecipitation with an anti-HA antibody.
To have an internal control for immunoprecipitation, an
antibody to actin was also added to each immunoprecip-
itate (Fig. B, lanes 1–6). One half of the immunoprecipi-
tates were used for Western analysis with anti-PI3-kinase
antibody (Fig. 5, panel A) and the second half were used
for Western analysis with anti-actin antibody (Fig. 5,
panel B). Coprecipitation of PI3-kinase was observed with
HA-immunoprecipitates made from osteoclasts trans-
duced with PBD (Panel A, lane 3), PBD (2) (lane 4), FL-
Gsn (lane 5) and NH-Gsn (lane 6) peptides. PI 3-kinase
was not detected in the HA-immunoprecipitates made
from osteoclasts transduced with Mid-Gsn peptide (lane
2), which does not contain PBD. This suggests that the
association of PI3 kinase with other peptides containing
PBDs is specific and indeed is mediated through the asso-
ciated phosphoinositides. Detection of more PI3-K levels
in FL-Gsn and PBD (2) transduced osteoclasts (lanes 4
and 5) may be due to the presence of multiple phosphoi-
nositide binding sites in these peptides. Western analysis
with an actin antibody (Fig. B) demonstrated equal
amount of actin in all the lanes. Gelsolin plays a key role
in the recruitment of signaling proteins such as, c-Src, PI
3-Kinase, p130Cas, FAK, integrin αvβ3, vinculin, talin and
paxillin to the podosome signaling complex through
phosphoinositide-protein interactions [16]. We failed to
The effects of transduction of TAT-fused gelsolin proteins on PtdIns P2 association with endogenous gelsolin Figure 4
The effects of transduction of TAT-fused gelsolin proteins on PtdIns P2 association with endogenous gelsolin 
Osteoclasts were transduced with TAT-peptides and treated with PBS (-) or OPN (+) as indicated below the figure. Lysates 
were immunoprecipitated with a monoclonal antibody to gelsolin (lanes 1–8; 10–17) or non-immune serum (NI; lane 9). Panel 
A: Western analysis with an antibody to PtdIns P2. Arrows point to endogenous gelsolin (lanes 1–8 and 10–17) and the copre-
cipitated transduced TAT-gelsolin protein (lanes 16 and 17) associated with PtdIns P2. IgG heavy chain is also indicated by an 
arrow. Panel B: Western analysis with an antibody to gelsolin. The level of gelsolin in each lane is shown. Arrows indicate 
endogenous (lanes 1–8 and 10–17) and TAT-gelsolin (lanes 16 and 17) proteins. The results represent one of three experi-
ments performed from three separate osteoclast preparations.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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detect association of Src, FAK or other signaling molecules
complexed with these transduced proteins.
The ability of the transduced peptides containing PBD to
interfere the binding of PI3-Kinase with endogenous
gelsolin was investigated by Western analysis of anti-gel-
solin immunoprecipitates with an antibody to PI3-kinase
(Fig. 5, panels C and D). Osteoclasts transduced with vec-
tor protein, HA-TAT (Panel C, lane 2), Mid-Gsn (lane 3)
exhibited association of PI3-kinase with gelsolin. A signif-
icant decrease in the interaction of PI3-kinase was
observed in osteoclasts transduced with NH-Gsn (lane 4)
and PBD (lane 5) peptide transduced osteoclasts. Very
minimal or no interaction of PI3-kinase with endogenous
gelsolin was observed in osteoclasts transduced with pep-
tides containing multiple phosphoinositides binding
domains, such as PBD (2) (lane 6) and FL-Gsn (Lane 7).
The decrease or failure in association of PI3-kinase with
the endogenous gelsolin (Panel C) was parallel to the
increase in association of PI3-kinase with the transduced
peptides (Fig. A). Immunoprecipitation with a non-
immune serum is shown in lane 1. Panel D shows the lev-
els of gelsolin in each immunoprecipitate as control for
comparable loadings. These observations confirm the pre-
viously demonstrated specific interaction of PI3-kinase
with gelsolin [16].
Transduction of PBD containing gelsolin peptides disrupts 
actin ring and peripheral dot-like podosome structures
We have previously demonstrated that increased associa-
tion of phosphoinositides with gelsolin was accompanied
with actin cytoskeletal reorganization [13,14]. Therefore,
actin organization in response to transduction of various
peptides was analyzed by staining the osteoclasts with
rhodamine phalloidin (Fig. 6). The localization of trans-
duced peptides was identified by immunostaining the
cells with an antibody to HA and viewing under confocal
microscopy (Fig. 6). As demonstrated earlier [14], F-actin
enriched dot-like podosomal organization with actin ring
at the periphery was observed in osteoclasts treated with
either PBS (untransduced; A) or transduced with TAT-vec-
tor protein (B) and Mid-GSN fragment (E) (indicated by
Analysis of association of PI3-kinase with transduced TAT-HA peptides Figure 5
Analysis of association of PI3-kinase with transduced TAT-HA peptides Osteoclasts were transduced with TAT-pep-
tides as indicated below the panels A and C. Panel A: Western analysis using an antibody to PI3-kinase. Lysates were immuno-
precipitated with antibodies to HA and actin (lanes 1–6). Actin antibody was used as an internal control for 
immunoprecipitation. Immunoprecipitation with a non-immune serum (NI) is shown in lane 7. Panel B: Western analysis with 
an actin antibody. Panel C. Detection of association of PI3-kinase with endogenous gelsolin. Lysates were immunoprecipitated 
with a monoclonal antibody to gelsolin (lanes 2–7) or non-immune serum (NI; lane 1). Panel D: Western analysis using an 
antibody to gelsolin. To detect the levels of gelsolin, the immunoblot shown in panel C was stripped and blotted with an anti-
body to gelsolin. PI3-kinase, actin, gelsolin, and IgG heavy chain (IgG HC) protein bands are indicated by arrows. The results 
shown are representative of three independent osteoclast preparations and experiments.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
Page 9 of 21
(page number not for citation purposes)
arrows). Colocalization of the transduced peptides with F-
actin was not observed in these osteoclasts. Co-localiza-
tion of the transduced peptides with actin (yellow color)
was observed in punctate dot-like and patchy structures in
osteoclasts transduced with FL-GSN (Fig. C), NH-GSN
(Fig. D), COOH-GSN (Fig. F), PBD (Fig. G), and PBD (2)
(Fig. H) peptides. These structures were not observed in
the clear zone area of osteoclasts (compare C, D, F, and G
to A, B, and E). Moreover, the patchy structures (indicated
by arrow heads in Figs. C, D, F, G. and H) comprise
numerous punctate dot-like structures. A magnified view
of a patch (indicated by white square in Fig. H) is shown
in Fig. I. In addition to the above changes, transduction of
these peptides also caused dissolution of the peripheral
actin ring-like structures in these osteoclasts. The trans-
duced gelsolin peptides were localized diffusely through-
out the cytoplasm as well as in vesicles (Fig. 6; C-H).
Osteopontin has no effect on the organization of actin ring 
and podosomes in osteoclasts transduced with various 
gelsolin peptides containing PBD
Next, we analyzed the effects of OPN on the distribution
of podosomes (Fig. 7). Consistent with our previous
observations [14], OPN stimulated F-actin rich podo-
somes formation throughout the surface of osteoclasts
transduced with TAT-HA (B) and Mid-GSN (D) peptides.
Podosome organization in the clear zone area is shown in
PBS-treated TAT-HA protein transduced control osteoclast
(A). Similar to the observation shown in Fig. 6, osteoclasts
transduced with FL-GSN (C) or PBDs (E and F) demon-
strated changes in the organization of F-actin enriched
punctate structures, which was accompanied by a loss of
peripheral actin ring-like structure in these osteoclasts (C,
E, and F).
Transduction of PBD containing gelsolin peptides 
increases the F-actin content but has no effect on 
endogenous gelsolin-actin ratios
Transduction of PBD containing TAT-Gsn fragments as
well as FL-Gsn decreases the association of
phosphoinositides to endogenous gelsolin (Fig. 4). Sub-
sequently, we tested the hypothesis that increasing the gel-
solin peptide levels by transduction would block the
ability of OPN to stimulate a change in endogenous gel-
solin/actin ratios. Osteoclast lysates, which were immun-
odepleted for the transduced peptides by
immunoprecipitation with an anti-HA antibody, were
subjected to a second immunoprecipitation with an anti-
gelsolin antibody. We immunoprecipitated the EGTA-
resistant gelsolin-actin complexes from lysates made from
The effects of TAT-HA proteins transduction on actin distribution Figure 6
The effects of TAT-HA proteins transduction on actin distribution Confocal microscopy images of mouse osteoclasts 
stained for actin (red) and HA-protein (green) are shown. An actin enriched patch marked by a white square in Fig. H is magni-
fied in Fig. I. Yellow color indicates the colocalization of transduced peptides with actin. Immunostaining with a non-immune 
(NI) serum is shown in Panel J. Scale bars- 25 µm (Panels A-H and J) and 5 µm (Panel. I). Arrowheads indicate patches enriched 
in transduced peptides and actin (Panels C, D, F, G, and H). Arrows indicate typical podosome structures in panels A, B, and E. 
The results shown are representative of three independent osteoclast preparations and experiments.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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osteoclasts transduced with the indicated proteins shown
in Fig. 8. Consistent with our previous observation [13],
OPN treatment of osteoclasts transduced with HA-TAT
(Fig. 8, lane 2) and Mid-Gsn (lane 6) fragment exhibited
a decrease in gelsolin/actin ratios as compared to the PBS-
treated controls (lanes 1 and 5). The gelsolin/actin ratio
was similar in both PBS- and OPN-treated osteoclasts
transduced with FL-Gsn (lanes 3 and 4) and its PBD (2)
(lanes 7 and 8), COOH-Gsn (lanes 10 and 11) and NH-
Gsn (lanes 12 and 13) fragments. Neither actin nor gelso-
lin was observed in the non-immune serum immunopre-
cipitation made from lysates of OPN-treated osteoclasts
transduced with PBD (2) fragment (lane 9). The actin and
gelsolin bands were scanned and the actin/gelsolin ratio
in the complex was calculated. Table 1 shows the quanti-
tative changes in the actin-gelsolin ratios as measured
from the EGTA-resistant fraction of endogenous gelsolin
bound to actin. Consistent with our previous
observations, anti-gelsolin immunoprecipitates of EGTA-
treated cell lysates from OPN-treated cells demonstrated a
decrease in the amount of actin bound to gelsolin. Osteo-
clasts from PBS-treated or transduced with HA/TAT (vec-
tor protein) demonstrated an actin-gelsolin ratio of 1.45 ±
0.15, and 1.33 ± 0.09, respectively. A decrease in actin/gel-
solin ratio was observed in osteoclasts untransduced or
transduced with HA-TAT and TAT-Mid-Gsn and stimu-
lated with OPN (Table 1). This decrease was not observed
in osteoclasts transduced with FL-GSN as well as its frag-
ments NH-GSN, COOH-GSN, and PBD and treated with
OPN. Thus, transduction of PBD containing gelsolin pep-
tides blocked the effects of OPN to decrease gelsolin/actin
ratios in osteoclasts, which we interpret to mean that the
stimulation of actin uncapping by OPN was abrogated.
Although there were no changes in endogenous gelsolin/
actin ratio, the increase in the F-actin enriched structures
in osteoclasts transduced with various TAT-gelsolin fusion
proteins containing PBD (Fig. 6) prompted subsequent
investigations on the levels of F-actin content in these
osteoclasts (Table 1). Consistent with our previous obser-
vations, OPN stimulated F-actin content in osteoclasts
prepared from wild type (WT) mice [13]. An increase in F-
actin content was detected in WT osteoclasts transduced
with FL-GSN, NH-GSN, COOH-GSN, and PBD proteins.
Even though, there is a small increase in the patchy F-actin
enriched structures in OPN-treated osteoclasts transduced
with FL-GSN or PBD containing peptides (Fig. 6C,6E and
6F), no significant additional effect of OPN in increasing
the F-actin content was observed in these osteoclasts. In
Gsn-null osteoclasts, neither transduction nor OPN treat-
ment had any effect on F-actin content as demonstrated
earlier (data not shown; [15]).
Transduction of PBD containing gelsolin peptides 
decreases bone resorption activity of osteoclasts
Actin ring formation is a prerequisite for efficient bone
resorption. Hence, we analyzed the effects of transduction
of TAT/FL-GSN and gelsolin peptides on osteoclast bone
resorption activity (Fig. 9). Consistent with our previous
observations [14,15], OPN stimulated bone resorption
and the formation of multiple overlapping resorption pits
in untransduced (B), Mid-GSN (H), and Hsv-TK (P)
transduced osteoclasts as compared to PBS-treated respec-
tive controls (A, G, and O). Transduction of FL-GSN (C),
NH-GSN (E), COOH-GSN (I), PBD (K), and PBD (2) frag-
ment (M) exhibited smaller or equal size of pits compared
to control osteoclasts (A and O). OPN treatment had no
effect in increasing the pit area in these osteoclasts (D, F,
J, L, and N). Quantitating resorption pits on multiple den-
tine slices per treatment demonstrates a significant
increase in pit area in osteoclasts untransduced, trans-
duced with mid-Gsn or HSV-TK and treated with OPN
(Fig. 10). This was not observed in osteoclasts transduced
with gelsolin peptides containing PBD and treated with
OPN (D, F, J, L, and N).
Transduction of PBD containing gelsolin peptides reduces 
the association of phosphoinositides with WASP and Ezrin 
proteins
We analyzed OPN stimulation of PtdIns P2 association
with some of the candidate proteins involved in the regu-
lation of actin cytoskeleton such as, α-actinin, gelsolin,
and profilin. Our results demonstrated that OPN stimula-
tion of osteoclasts had no effect on PtdIns P2 association
with vinculin, α-actinin, and profilin [13]. Recent studies
The effects of TAT-HA-protein transduction and osteopon- tin on actin distribution Figure 7
The effects of TAT-HA-protein transduction and 
osteopontin on actin distribution Confocal microscopy 
images of mouse osteoclasts stained for actin are shown. 
Scale bar- 25 µm. Arrows point to patches enriched in F-
actin. The results represent one of three experiments 
performed.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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have demonstrated that podosomes are not formed in
macrophages harboring mutations in the Wiscott-Aldrich
Syndrome protein (WASP) [47]. PtdIns P2 association has
been shown to activate WASP [48] and ERM proteins
[49,50]. Here we have demonstrated that in addition to
gelsolin, OPN stimulation of PtdIns P2 association with
ezrin (Fig. 11, lane 1) and WASP (lane 5) was observed.
The levels of PtdIns P2 associated with WASP (lane 3) and
ezrin (lane 7) were reduced in osteoclasts transduced with
TAT-PBD (2) peptide and treated with OPN as compared
Analysis of the effects of transduction of PBD containing gelsolin peptides and osteopontin on endogenous gelsolin-actin ratio Figure 8
Analysis of the effects of transduction of PBD containing gelsolin peptides and osteopontin on endogenous gel-
solin-actin ratio Osteoclasts were transduced with indicated TAT-proteins and treated with OPN (denoted as (+)) or PBS 
(denoted as (-)). Equal amount of lysates were immunoprecipitated with anti-gelsolin antibody. The EGTA-resistant gelsolin/
actin complex was subjected to SDS-PAGE as described in the Methods section. Immunoprecipitation with a non-immune 
serum (NI) is shown in lane 9. Western analysis was performed with antibodies to gelsolin and actin. Gelsolin, actin, and IgG 
heavy chain (IgG Hc) bands are indicated by arrows. The quantitative changes in the actin/gelsolin ratio were determined by 
scanning the gelsolin and actin bands. The mean ± SEM for three experiments is provided in Table 1.
Table 1: The effects of HA-TAT-protein transductions and OPN treatment on gelsolin/actin ratio and F-actin content of osteoclasts. F-
actin content was measured by rhodamine-phalloidin binding in osteoclasts treated as indicated in the table. About 4–5 wells were used 
for each treatment. The experiment was repeated three times. The data presented are mean ± SE for three experiments.
Gelsolin/actin ratioF - a c t i n  c o n t e n t
OCs transduced with PBS OPN PBS OPN
Untransduced 1.45 ± 0.15 0.82 ± 0.18•• 1.0 3.5 ± 0.09***, *
Tat/FL-Gsn 1.3 ± 0.15 1.23 ± 0.08 2.5 ± 0.32 * 3.2 ± 0.81*
Tat/NH-Gsn 1.32 ± 0.13 1.35 ± 0.15 1.95 ± 0.05* 2.6 ± 0.06*
Tat/Mid-Gsn 1.38± 0.18 0.71 ± 0.06•• 1.20 ± 0.11 3.1 ± 0.33 **, °°°
Tat/PBD 1.42 ± 0.16 1.37 ± 0.14 2.17 ± 0.22* 2.2 ± 0.2 *
Tat/PBD(2) 1.36 ± 0.11 1.44 ± 0.21 2.19 ± 0.10* 2.6 ± 0.23*
Tat/COOH-Gsn 1.35 ± 0.12 1.41 ± 0.14 2.11 ± 0.11* 2.8 ± 0.09*
HA-TAT 1.33± 0.09 0.73 ± 0.07•• 1.092 ± 0.02 3.6 ± 0.15 °°°
••p < 001-OPN, Mid-Gsn/OPN, and HA-TAT/OPN-treated vs. respective PBS-treated osteoclasts °°°p < 0.0001 Mid-Gsn/OPN and HA-TAT/OPN-
treated vs. HA-TAT/PBS-treated osteoclasts *p < 0.01-PBS, OPN-treated TAT-fusion proteins transduced osteoclasts vs. PBS-treated 
untransduced (-) and HA-TAT transduced control osteoclasts **p < 001-OPN-treated Mid-GSN transduced osteoclasts vs. PBS-treated Mid-Gsn 
transduced osteoclasts *** p < 0.0001-OPN-treated osteoclasts vs. untransduced PBS-treated (-) osteoclastsBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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to OPN alone treated osteoclasts (lanes 1 and 5). Immu-
noprecipitation with non-immune serum (NI) is shown
in lanes 4 and 8.
Transduction of PBD containing gelsolin peptides reduces 
the interaction of WASP with Arp3 protein
Arp2/3 complex plays a key role in actin polymerization
and contractile ring (actin ring) formation in yeast cells
[51]. Arp2/3-WASP complex is essential for the structures-
like podosomes [52] and lamellipodia [53]. Therefore, we
hypothesized that WASP-Arp2/3 complex formation
would be blocked in osteoclasts transduced with gelsolin
fragments containing PBDs. Our observations have sup-
ported this hypothesis and demonstrated that transduc-
tion of gelsolin fragments containing PBD indeed blocked
the Arp2/3–WASP complex formation (Fig. 12). Lysates
made from osteoclasts transduced with FL-GSN and PBD
(2) were subjected to immunoprecipitation with anti-
The effects of TAT-HA-protein transduction and osteopontin on bone resorption Figure 9
The effects of TAT-HA-protein transduction and osteopontin on bone resorption Osteoclasts were transduced or 
treated with indicated proteins. Panels A-P: Pits were viewed under 40× objective in a phase contrast microscope and photo-
graphed. Each treatment was performed in triplicates. The experiment was repeated three times with three independent oste-
oclast preparations. The results represent one of the three experiments performed.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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Arp3 antibody and Western analyzed with WASP anti-
body. Coprecipitation of WASP with Arp3 was observed
in PBS-treated osteoclasts either untransduced (lane 8) or
transduced with Mid-Gsn fragment (lane 7). This interac-
tion was more in OPN-treated osteoclasts (lanes 7 and 9).
Neither basal level association of Arp3 with WASP nor
OPN stimulation was observed in osteoclasts transduced
with either FL-Gsn (lanes 2 and 3) or tandem repeats of
PBD (lanes 4 and 5). Panel B demonstrates the levels of
Arp3 in each immunoprecipitates. Arp3
immunoprecipitates from mid-Gsn transduced osteo-
clasts exhibited a decrease in the intensity of Arp 3 levels
in PBS- (Panel B, lane 6) and OPN- (lane 7) osteoclasts
despite more WASP having been coprecipitated (Panel A,
lanes 6 and 7) as compared to FL-GSN (lanes 2 and 3) or
PBD-transduced (lanes 4 and 5) osteoclasts.
Immunoprecipitation with non-immune serum is shown
in lane 1 (Panels A and B).
Discussion
On the basis of our previous reports demonstrating the
role of gelsolin in osteoclast cytoskeletal reorganization
and cell shape changes, we proposed the hypothesis that
gelsolin-polyphosphoinositides association was critical to
osteoclast function. The results presented here
demonstrate that transduced gelsolin peptides, which
contain PBDs, associated with polyphosphoinositides,
PI3-kinase and actin. Furthermore, the levels of associated
polyphosphoinositides were regulated by OPN. The trans-
duced PBD containing peptides caused randomly distrib-
uted podosome-like structures. However, the transduced
peptides were not targeted to sites of podosome
organization in the sealing zone, and they did not substi-
tute or enhance endogenous gelsolin function. Rather,
they served dominant negative functions by decreasing
polyphosphoinositides binding with endogenous gelso-
lin, and causing loss of peak stimulation of polyphosph-
oinositides/gelsolin association in response to OPN. The
results regarding osteoclast cytoskeleton were a loss of
functional podosomes and actin ring. In cell function
terms, the results were bone resorption inhibition, hypo-
motility, and loss of stimulation in response to osteopon-
tin. The finding that limiting polyphosphoinositides
associated with gelsolin disables podosome assembly and
organization of the actin ring demonstrates that
polyphosphoinositides-mediated signaling is critical to
osteoclast cytoskeletal organization, OPN/αvβ3 signaling,
and cell function.
Measurement of pit area Figure 10
Measurement of pit area. About 25 to 30 pits/slice and three slices from each experiment were scanned. Data shown are 
mean ± SEM of three experiments. *** p < 0.0001-PBS-treated or Hsv-TK transduced osteoclasts vs. OPN-treated osteoclasts 
**p < 0.001-OPN alone or Mid-Gsn/OPN-treated osteoclasts vs. PBD (2)/OPN-treated osteoclasts. *p < 0.01 OPN-treated, 
Mid-Gsn/OPN-treated osteoclasts vs. FL-Gsn/OPN, NH-Gsn/OPN, CT-Gsn/OPN, PBD/OPN-treated osteoclasts.
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We have previously demonstrated that gelsolin is a high
affinity barbed-end-capping protein in osteoclasts [13].
Actin polymerization is increased in osteoclasts treated
with OPN. Osteoclasts dependent on actin filaments with
free barbed ends, for podosome organization and actin
ring formation. Here, we have demonstrated that osteo-
clasts transduced with PBD containing gelsolin peptides
failed to exhibit dissociation of endogenous gelsolin from
actin filaments in OPN-treated osteoclasts. Therefore,
actin/gelsolin (endogenous) ratio was found to be
unaffected in both PBS and OPN-treated osteoclasts.
Transduction of PBD containing peptides disrupted
regulated dissociation of gelsolin from actin filaments as
well as actin polymerization as shown in Fig. 8. Binding
of phosphoinositides has previously been shown in seg-
ment 2, which can induce dissociation of actin-gelsolin
complexes (uncapping) [23-25]. The mechanism by
which gelsolin regulates actin polymerization is not
completely understood. Deletion of S2-3 segments con-
taining the first half PBD domains demonstrated a delete-
rious effect on cells. Cells exhibited an abnormal shape
and complete disruption of the actin cytoskeleton [54].
Introduction of synthetic cell permeant peptide derived
from the polyphosphoinositides binding region was
shown to disassemble actin filament structures and
blocked motility in fibroblasts, platelets, neutrophils, and
melanoma cells [43]. These studies are compatible with
our results (Figs. 6 and 7) demonstrating loss of the actin
ring at the periphery as well as formation of actin-
enriched abnormal large patchy structures and larger size
podosomes-like structures randomly throughout the ven-
tral surface of the cell.
Increasing the PBD content in osteoclasts by transduction
enhances local accumulation of phosphoinositides. The
transduced peptides have varied numbers of PBD i.e. one
in NH-GSN, 2 in PBD, three in FL-GSN, and four in PBD
(2). The effects of phospholipid were more pronounced
with peptide containing PBD (2). The interaction is rank
ordered as NH-Gsn = PBD < FL-GSN < PBD (2) by the
amount of polyphosphoinositides (PtdIns P2 and -P3)
binding (Fig. 2; panel B). Also, binding of transduced PBD
peptides with F-actin is evident from the staining of
osteoclasts with rhodamine phalloidin. Co-localization of
the transduced peptides with F-actin was observed in
patchy as well as dot-like podosome structures. Recently,
Akisaka et al have demonstrated that structures exhibiting
patchy podosomes demonstrated colocalization of F-and
G-actin [55]. In the present study, binding of transduced
PBD peptides with F-actin is evident from the staining of
osteoclasts with rhodamine phalloidin. Also, amino acid
residues 168RRV170 in PBD 2 are predicted to prevent
Transduction of PBD containing gelsolin peptides reduces the association of phosphoinositides WASP and Ezrin proteins Figure 11
Transduction of PBD containing gelsolin peptides reduces the association of phosphoinositides WASP and 
Ezrin proteins Panel A: Western analysis with an antibody to PtdIns P2. Osteoclasts were treated as indicated in the figure. 
The lysates were immunoprecipitated with either ezrin (lanes 1–3) or WASP (lanes 5–7). Immunoprecipitation with non-
immune serum is shown in lanes 4 and 8. Arrows point to IgG HC as well as PtdIns P2 (PIP2) associated ezrin and WASP pro-
teins. Panel B: Western analysis with an antibody to ezrin or WASP. Arrows indicate ezrin and WASP proteins. The results 
represent one of three experiments performed.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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gelsolin domain 2 from binding to monomeric actin (G-
actin). PBD (2) present in the amino acid residues 161–
169 has the predicted 168Arg-Arg169 (RR) amino
sequences, which will block gelsolin domain 2 from bind-
ing to monomeric actin. It appears that the patchy struc-
tures in PBD transduced osteoclasts is not due to
accumulation of G-actin. Hence these patchy may be due
to the accumulation of F-actin as well as a decrease in F-
actin turnover rate.
We have documented two important roles of phosphoi-
nositides associated with gelsolin in osteoclasts; those are
a) Uncapping of actin by PtdIns P2 binding to gelsolin
[13]. b) Unique mechanism of PtdIns P3-SH2 mediated
signal generating complex formation in osteoclast podo-
somes [16]. Does transduction of PBD affect PI3-K associ-
ated with endogenous gelsolin? An important insight into
the role of phosphoinositides results from the finding that
PtdIns P3 associates directly with the SH2 domain of
kinase and that PtdIns P3 also disrupts the association of
PI3-K with tyrosine phosphorylated proteins by binding
to the SH2 domains of the p85 subunit [56]. We have
previously demonstrated that SH2 domains of Src and
PI3-kinase also bind PtdIns P2, albeit more weakly than
their binding to PtdIns P3. Since PtdIns P2 is a substrate
for PI3-kinase, the increase in the formation and associa-
tion of PtdIns P3 with the transduced PBD containing
peptides is mediated through preferential interaction of
PI3-kinase. Here, we demonstrate that transduction of
PBD containing gelsolin fragments have a dominant neg-
ative effect in the aspect of limiting the availability of
phosphoinositides to the endogenous gelsolin as shown
Transduction of PBD containing gelsolin peptides reduces the interaction of WASP with Arp3 protein Figure 12
Transduction of PBD containing gelsolin peptides reduces the interaction of WASP with Arp3 protein Osteo-
clasts were transduced with indicated TAT-proteins and treated with OPN (denoted as (+)) or PBS (denoted as (-)). Equal 
amount of lysates were immunoprecipitated with anti-Arp3 antibody (lanes 2–9) and non-immune serum (NI, lane 1). The 
immunoprecipitates were subjected to SDS-PAGE. Panel A. Western analysis with a WASP antibody. Arrow points to WASP 
protein. Panel B. Western analysis with an Arp3 antibody. The immunoblot shown in panel A was stripped and blotted with 
an Arp 3 antibody to detect the levels of Arp 3 in each immunoprecipitates. The results represent one of three experiments 
performed.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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in Fig. 4. Since the transduced PBD peptides limit the
availability of PtdIns P2 to endogenous gelsolin, it limits
PI3-kinase interaction as well. The increase in PtdIns P3
levels associated with the transduced PBD containing frag-
ments (Fig. 2B) indicates that the associated PI3-kinase is
active. The signaling complex formation in the podo-
somes could be the direct means for assessing the active
nature of the podosomes required for osteoclast function.
Even though, PI3-kinase was co-precipitated with the
transduced peptides, we do not observe co-precipitation
of Src, FAK or other signaling molecules (Chellaiah,
unpublished observations [2]) indicating that the patchy
podosome-like actin enriched structures do not exhibit
normal organization of podosome with respect to signal-
ing complex formation. This also confirms our previously
demonstrated observation of PI3-kinase as an immediate
interacting protein with gelsolin [16].
OPN was shown to increase the PtdIns P2 levels associ-
ated specifically with gelsolin and not with other proteins
that bind to phosphoinositides such as, vinculin, α-
actinin, or profilin [13]. Phosphoinositides have also
been identified as key regulator of members of two fami-
lies of proteins, ERM and WASP [48,57-59]. PtdIns P2 and
Rho GTPases have been shown to be the upstream signal-
ing molecules in WASP-Arp2/3 complex formation
[48,60-63] as well as in the activation of ERM proteins
[49].We have previously demonstrated that ERM activa-
tion is required for its interaction with CD44 receptor and
surface expression of CD44 [64]. WASP has been shown
to recruit the Arp2/3 complex into podosomes [65].
Podosomes are not formed in cells null for WASP [66] or
harboring mutations in the WASP [65]. More recently,
Calle et al., have demonstrated that WASP-null osteoclasts
are markedly depleted of podosomes. On bone surfaces,
osteoclasts fail to form actin rings at sealing zones [67].
We have shown here that OPN stimulated WASP-Arp2/3
complex formation. Transduction of PBD of gelsolin
blocked this complex formation. WASP distribution was
observed in podosomes and actin ring of osteoclasts.
Osteoclasts transduced with PBD failed to demonstrate
WASP in the newly formed podosomes or in the actin ring
area (unpublished observations). These observations
demonstrate that transduction of PBD containing gelsolin
fragment exhibit dominant negative effect not only on
gelsolin function but also on other phosphoinositides
binding proteins such as N-WASP and ezrin.
Cells exhibiting podosomes have been shown to be highly
motile. Osteoclasts are uniquely motile in that they con-
tinue to resorb bone beneath one area of the cell under-
surface while another area of cell is reorganizing and
moving [68]. The result is the production of complex
multiple overlapping resorption pits as shown in Fig. 9
(Figs. B, H, and P). The rapidity of podosome assembly
and disassembly enables this feature of coordinating cell
function with motility [33,69]. Osteoclasts from gelsolin
null mice (Gsn-/-) are hypomotile due to retarded remod-
eling of the actin cytoskeleton [15]. Despite distinct podo-
some structures are not present in Gsn-/- osteoclasts, actin
ring was clearly observed. In Gsn-/- osteoclasts, we did not
observe any redundancies within the gelsolin-mediated
signaling pathway in podosomes assembly [15]. The pres-
ence of actin ring in Gsn-/- osteoclasts indicates the func-
tion of WASP in the formation of actin ring. Actin ring
formation is required for bone resorption but is not
required for motility. With OPN stimulation of αvβ3
integrin, podosomes assembly proceeds by gelsolin/actin
dissociation. We fail to observe dissociation of
endogenous gelsolin from actin in osteoclasts transduced
with PBD containing gelsolin peptides. The dominant
negative effect of the transduced proteins, limiting
polyphosphoinositides association with endogenous
gelsolin was the most likely mechanism causing failure of
new podosome assembly. While gelsolin content is a fac-
tor in controlling the motility, our results demonstrate
that its appropriate targeting to the sealing zone is criti-
cally involved in osteoclast cytoskeletal reorganization,
cell shape changes, and cell motility. In addition, the
nucleating, severing and actin binding functions of gelso-
lin are responsible for variations between motile and non-
motile status of a cell [19]. Further analyses of the roles of
phosphoinositides as well as WASP-Arp2/3 complex for-
mation in podosomes assembly and actin ring formation
will give insight into the molecular mechanisms involved
in these processes. The data presented here suggests addi-
tional role of phosphoinositides in actin ring formation,
leading to a critical avenue for future research.
Conclusions
Microinjection or transfection of 'VCA' and 'CA' domains
of N-WASP into cells of interest has been shown to func-
tion as a constitutively active and dominant negative frag-
ments, respectively in Arp2/3 complex activation [2].
Here, we have demonstrated permeable peptides contain-
ing PBD, which has dominant negative effect on the
formation of podosomes and actin ring in mouse osteo-
clasts. These biologically active permeable PBD contain-
ing peptides function as inhibitors of motility and bone
resorption activity in vitro in osteoclasts. Regardless of the
type of receptors or signaling pathways, down stream
molecules involved in actin cytoskeleton and motility are
the same. Therefore, these peptides can be used as a tool
to delineate phosphoinositides-mediated signaling
orchestrating motility of various cell types involved in
inflammatory responses, angiogenesis, normal develop-
ment, osteoporosis, and cancer metastasis.BMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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Methods
Materials
PtdIns P2 antisera was purchased from Advanced Magnet-
ics (Cambridge, MA) and Echelon Research Laboratories
Inc. (Salt Lake City UT). Monoclonal antibodies to gelso-
lin and hemagglutinin (HA) antibodies, non-immune
mouse IgG, and rabbit IgG, Protein A-Sepharose, phos-
pholipids standard, and all the other chemicals were pur-
chased from Sigma Chemical Co. (St. Louis, MO).
Antibodies to PI3-kinase and Src were purchased from
Santa Cruz Biotechnology, Inc (Santa Cruz, CA) and
Oncogene Research Products, Boston, MA), respectively.
Rainbow molecular weight marker and [32P]
orthophosphate were obtained from Amersham Pharma-
cia Biotech (Piscataway, NJ). Protein estimation reagent,
molecular weight standards for proteins, and PAGE rea-
gents were bought from Bio-Rad (Hercules, CA).
Generation of murine osteoclasts in vitro
Mouse osteoclasts were generated in vitro using mouse
bone marrow cells as described previously [15]. Cells were
cultured with the appropriate concentrations of mCSF1
(10 ng/ml; R & D systems) and RANKL (55–75 ng/ml).
After 3 days in culture, media were replaced with fresh
cytokines. Multinucleated osteoclasts were seen from day
4 and 90–95% TRAP-positive osteoclasts were observed
from day 5 onward.
Cloning of gelsolin fragments into TAT-HA vector
Bacterial expression of constructs coding various HIV-TAT
fusion peptides of gelsolin were generated by in-frame
insertion of full-length human plasma gelsolin cDNA
[37], as well as its fragments (Fig. 1, Panel A) into a vector,
pTAT-HA. pTAT-HA vector has an N-terminal 6-histidine
leader followed by the 11 aa TAT-protein transduction
domain flanked by glycine residues, a hemagglutinin
(HA) tag, and a polylinker [46,70]. The clone encoding
the full-length gelsolin (FL-GSN) included a single open
reading frame of about 754 amino acids with nucleotide
sequences from 160 to 2357 bp. Two primers were made
that enabled the amplification of FL-GSN from sequences
160–2357 bp was: 5'CC AAC AGC ATG GTG GTG GAA C
3' (160–180 bp) and 5'CCG CGG CTCAGC CAT GGC
CCT GTC (2334–2357 bp). The following fragments were
generated by restriction digestion of full-length gelsolin
DNA with kpn 1 enzyme: NH-terminal fragment 169–551
bp; middle fragment: 861–1569 bp; COOH-terminal frag-
ment: 1569 to 2357 bp. These DNA fragments were puri-
fied and cloned into the kpn1 site of HIV-TAT vector.
Phosphoinositides binding domains (PBDs) 1 and 2 were
created by cloning PCR generated fragments using the fol-
lowing primers: 493–519 bp; 5' ACT TCA AGT CTG GCC
TGA AGT ACA AGA-3' and 585–602 bp; 5'-ACG CCG
CCC TTT GAC CTG3'. The PCR products (FL-GSN and
PBDs) were cloned into PCR 2.1 vector. The FL-GSN, and
the PBDs of gelsolin were digested with EcoR1 enzyme,
purified, and cloned into TAT-HA vector (Fig. 1B). The
sequences of all the clones were confirmed for reading
frame by DNA sequencing.
Expression and purification of HA-TAT peptides
Escherischia coli-BL21 (Invitrogen, Carlsbed, CA) was
used to transform the HIV-Tat containing gelsolin and its
fragments. Bacteria were grown overnight in LB medium
containing 100 µg/ml ampicillin. The cultures were
induced with 1 mM IPTG for 3–4 h. Cells were sonicated
and protein was purified using Ni-NTA column as
described [46,70]. Herplex simplex virus thymidine
kinase (Hsv-TK) protein (42 kDa) and TAT-HA vector (6–
8 kDa) peptides were used as non-specific protein con-
trols. The purified proteins were subjected to SDS-PAGE
and Western analysis with a hemagglutinin (HA) anti-
body to HA-tag present in the TAT-fusion protein.
Western analysis with a mono- and polyclonal antibody
to gelsolin was also performed. The sequences of all the
clones were confirmed for reading frame by DNA
sequencing.
TAT-transduction into osteoclasts and preparation of 
lysates
After 4 or 5 days in culture, osteoclasts were either trans-
duced with TAT-gelsolin peptides or treated with OPN to
a final concentration of 25 µg per ml for 15 min. at 37°C
as described [49]. For transduction, TAT peptides were
added to cells to a final concentration of 100 nM in
serum-free medium, after osteoclasts were kept in serum-
free α-MEM for 2 h. Dose and time-dependent uptake of
peptides were determined. Maximum uptake was
observed between 20–60 min. We chose a 45 min. time
period for the incubation with TAT peptides. After treat-
ments with TAT peptides or OPN, lysates were made using
Triton containing lysis buffer (10 mM Tris-HCl, pH 7.05;
50 mM NaCl; 0.5% Triton X-100; 30 mM sodium pyro-
phosphate; 5 mM NaF; 0.1 mM Na3VO4; 5 mM ZnCl2;
and 2 mM PMSF). Protein contents were measured using
the Bio-Rad protein assay reagent kit.
Immunoprecipitation and Western analysis
Equal amounts of lysate proteins were precleared with
protein A-sepharose, presoaked in lysis buffer containing
BSA, and with non-immune IgG coupled to sepharose.
The precleared supernatants were incubated with either
HA or gelsolin antibodies and the immune complexes
were adsorbed onto protein A-sepharose beads. The beads
were pelleted and washed three times for 5 min. each with
ice-cold PBS. The immune complexes were then eluted by
in electrophoresis sample buffer and analyzed on 8% or
15% SDS-PAGE depending on the molecular weight of
the proteins of interest. The proteins were transferred to a
PVDF membrane for Western analyses. Blots were blockedBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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with 10% milk in PBS containing 0.5% Tween (PBS-T) for
2–3 h and then incubated with 1:100 dilution of primary
antibody of interest (antibody to PtdIns P2, actin, gelso-
lin, or PI3-kinase) for 2–3 h. After three washes for 10
min. each with PBS-T, the blot was incubated with a
1:1000 dilution of peroxidase-conjugated species-specific
respective secondary antibody for 2 h at room tempera-
ture. After three washes for 10 min. each with PBS-T,
protein bands were visualized by chemiluminescence
using the ECL kit (Pierce) [13-15].
32P labeling of cells and TLC analysis of phosphoinositides
After 4 days in culture, osteoclasts were labeled with car-
rier-free [32P] orthophosphate for 2-h at 37°C as previ-
ously described [15]. After labeling, cells were washed
twice with serum-free medium and incubated with OPN
(25 µg/ml) for 15 min. or the indicated gelsolin peptides
in Fig. 5 for 45 min. at 37°C. Osteoclasts were washed
with cold PBS and lysates were made using Triton contain-
ing lysis buffer. Equal amounts of lysate proteins were
immunoprecipitated with the HA-antibody or non-
immune serum. Lipids were extracted from the immuno-
precipitates as described and dried in the speed vacuum
concentrator. The dried lipids were reconstituted in 100 µl
of chloroform: methanol (1:1) and spotted on silica gel
TLC plates pretreated with 1.2% potassium oxalate in
methanol and water (2:3). The plates were developed as
described and lipid spots were visualized by autoradiogra-
phy. Identification of the radioactive spots was carried out
by analyzing the migration of non-radioactive standards
as previously described [13].
Bone resorption assay
Whale dentine slices (1.5 cm2 across and 0.75 mm thick)
were cut and processed as described previously [15]. Oste-
oclasts were transduced with the indicated TAT peptides
(100 nM) in Fig. 9 or treated with OPN (10 µg/ml) as
described [46]. Cells were scraped gently after incubating
with the cell stripper solution (Cellgro by Media tech,
Inc.,) for 30 min. [71] and the osteoclast suspension (2 ×
104 cells) was added to each well. After 2-h of adherence,
the culture media were replaced with α-MEM containing
either mouse OPN alone (10 µg/ml) or TAT peptides with
and without OPN. After 24-h, the medium was replaced
with fresh medium containing the respective treatments.
Following incubation for 48-h, the slices were washed 7–
10 times with water and stained with acid hematoxylin
(Sigma, St. Louis, MO) for 6 min. After washing with
water several times, the stained pits were imaged under
40× objective in a Zeiss inverted-phase contrast micro-
scope fitted with a SPOT camera (Diagnostic Instruments,
Inc., Alexandria, VA, USA). The images were processed by
the Adobe Photoshop software program (Adobe Systems,
Inc.,). The area of pit was measured from the free-hand
traced perimeter using the Scantalytics software
(Scantalytics Inc., IP Lab, Fairfax, VA). Pit area was meas-
ured in 40× magnification. About 25 to 30 pits/slice and
three slices from each experiment were scanned. Experi-
ments were repeated three times with three independent
osteoclast preparations. Each treatment was performed in
triplicates. Statistical analysis was performed by analysis
of variance (ANOVA) with the Bonferroni corrections as
described below.
Immunostaining
After 5d in culture, osteoclasts grown on cover slides were
kept in serum-free medium for 2-h and treated with TAT-
fusion peptides or OPN as described above. Cells were
fixed and immunostained with a monoclonal antibody to
HA (1:100 dilution) as described [15]. F-actin was visual-
ized by co-staining the cells with rhodamine phalloidin
(1:100 dilution) as described [14]. Osteoclasts were pho-
tographed with a BIO-RAD confocal laser-scanning
microscope. Confocal images were processed by the
Adobe Photoshop software program (Adobe Systems,
Inc.,).
Measurement of F-actin content using rhodamine 
phalloidin binding
Osteoclast precursor cells were cultured in 24-well culture
plates for 4 days. The cells were subjected to various treat-
ments as indicated in Table 1 and washed three times with
PBS. Cells were fixed with 1.5% formaldehyde in PBS for
15 min. and permeablized with 0.1% Triton X-100 in PBS
for 5 min. The cells were rinsed three times for 5 min. each
with PBS and incubated with rhodamine phalloidin
(1:100 dilution of 1 mg/ml stock; v/v) for 30–45 min. at
37°C. The cells were washed quickly several times with
PBS and extracted with absolute methanol. The fluores-
cence of each sample was measured using fluorimetry
(Bio-Rad). The non-specific binding in the control exper-
iments was subtracted from the total binding to get the
specific binding in each sample [72]. Experiments were
repeated three times with three independent osteoclast
preparations. Three to four wells were used for each treat-
ment. Statistical comparisons were performed as men-
tioned in data analysis.
Immunoprecipitation of gelsolin/actin complexes
Equal amounts of lysate proteins were used for immuno-
precipitation with anti-gelsolin antibody. EGTA-resistant
gelsolin-actin complex was prepared from the immune
complexes absorbed to protein A sepharose as described
[73,74]. The absorbed proteins were washed with differ-
ent buffers as mentioned below. Initially, the beads were
washed twice with lysis buffer containing 5 mM ATP; then
three times with buffer containing 50 mM Tris-HCl pH
7.4, 0.5 M NaCl, 1 mM EGTA, and 0.3 M MgCl2; and then
finally, twice in 10 mM Tris-HCl, pH 7.4 and 100 mM
NaCl. The sepharose beads were boiled in electrophoresisBMC Cell Biology 2004, 5 http://www.biomedcentral.com/1471-2121/5/19
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sample buffer and analyzed on 8% SDS-PAGE. The pro-
teins were transferred to a PVDF membrane for immuno-
blot analyses. Blots were blocked with 10% milk in PBS
containing 0.5% Tween (PBS-T) for 2–3 h and then incu-
bated with 1:100 dilution of gelsolin and actin mono-
clonal antibodies for 2–3 h. After three washes for 10 min.
each with PBS-T, the blot was incubated with a 1:1000
dilution of peroxidase-conjugated mouse secondary anti-
body for 2 h at room temperature. After three washes for
10 min. each with PBS-T, protein bands were visualized by
chemiluminescence using the ECL kit (Pierce). The quan-
titative changes in the EGTA-resistant fraction of actin/gel-
solin ratio were determined by scanning the gelsolin and
actin bands using the Un-Scan It gel digitizing software
(Silk Scientific Inc. Orem, Utah). Statistical comparisons
were performed as mentioned in data analysis.
Data analysis
All comparisons were made as "% control", which refers
to vehicle-treated cells. The other treatment groups in each
experiment were normalized to each control value. Data
presented are mean ± SEM of experiments done at
different times normalized to intra-experimental control
values. For statistical comparisons, analysis of variance
(ANOVA) was used with the Bonferroni corrections
(Instat for IBM, version 2.0; Graphpad software).
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